Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients’ heart?

Caterina Fontanella1 Department of Oncology, University Hospital of Udine, Udine, ItalyCorrespondence[email protected]

Marianna Aita1 Department of Oncology, University Hospital of Udine, Udine, Italy

Marika Cinausero1 Department of Oncology, University Hospital of Udine, Udine, Italy

Giuseppe Aprile1 Department of Oncology, University Hospital of Udine, Udine, Italy

Maria Grazia Baldin2 Department of Cardiology, Palmanova General Hospital, Palmanova, Italy

Veronica Dusi3 Department of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Chiara Lestuzzi4 Department of Cardiology, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy

Gianpiero Fasola1 Department of Oncology, University Hospital of Udine, Udine, Italy

Fabio Puglisi1 Department of Oncology, University Hospital of Udine, Udine, Italy;5 Department of Medical and Biological Sciences, University of Udine, Udine, Italy

show all

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients’ heart?

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients’ heart?

Citations (5)

Articles from other publishers (5)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date